ProShares - UltraShort Nasdaq Biotechnology

ETFBISNASDAQ

0.00 n/a

+0.00%(+0.00)

About

The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.

Key Facts

Expense Ratio

3.20%

Assets Under Management

$2.70M

NAV

$16.34

Holdings

Inception Date

2010-04-07

Asset Class

Equity

Issuer

ProShares

Avg. Volume

9.07K

Market Cap

$2.29M

Beta

-1.18

52-Week Range

$14.75$14.87$35.68

52W LowCurrent52W High

Performance

1 Week

−10.96%

1 Month

−13.40%

3 Months

−24.13%

YTD

−21.57%

1 Year

−59.08%

3 Years

−61.62%

5 Years

−62.41%

Sector Exposure

Cash & Others
100.00%

Geographic Allocation

Other
100.00%

Top Holdings

Top Holdings
Symbol	Name	Weight	Market Value
—	Net Other Assets (Liabilities)	100.00%	$2.54M
—	NASDAQ Biotechnology Index SWAP Societe Generale	0.00%	$0
—	NASDAQ Biotechnology Index SWAP Citibank NA	0.00%	$0
—	NASDAQ Biotechnology Index SWAP UBS AG	0.00%	$0
—	NASDAQ Bio Index SWAP BNP Paribas	0.00%	$0
—	NASDAQ Biotechnology Index SWAP Bank of America NA	0.00%	$0